A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2002
12/04/2002	EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002	EP1180026B1 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
12/04/2002	EP1131304B1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
12/04/2002	EP1058683B1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
12/04/2002	EP1051420B1 New cytotoxic tris(oxazole)-containing macrolides
12/04/2002	EP1022277B1 New taxane derivatives
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002	EP0928291B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
12/04/2002	EP0907650B1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines
12/04/2002	EP0802915B1 Camptothecin derivatives and its manufacturing method
12/04/2002	EP0800390B1 Cyclopropylpyrroloindole-oligopeptide anticancer agents
12/04/2002	EP0719285B1 Il8 inhibitors
12/04/2002	EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
12/04/2002	EP0690856B1 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
12/04/2002	EP0650356B1 Rapamycin derivatives
12/04/2002	CN1383452A Compsns. and methods for treating cells having double minute DNA
12/04/2002	CN1383382A Use of methoxymorpholino dexorubicin for treatment of liver tumor
12/04/2002	CN1382493A Diarylprophin photosensitizer and its preparing process and usage
12/04/2002	CN1382448A Genetic switch medicine for treating tumor
12/04/2002	CN1382437A Application of epigallic catechin 3-gallate in treating HPV infection
12/04/2002	CN1095498C Saffron polyploid cell culture process to produce crosin
12/04/2002	CN1095472C Folica acid-polysaccharide composite and its prepn. and medical compsn. with composite as active component
12/04/2002	CN1095465C Chiral anonance-lactone compounds, and its synthesizing process and application
12/04/2002	CN1095336C Anti-cancer health tea and its prodn. method
12/03/2002	WO2001096365A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
12/03/2002	US6489514 (-)-Secoisolariciresinol as an antioxidant obtained from a new natural source namely stereospermum personatum
12/03/2002	US6489349 Treating an autoimmune disorder with an alkylamine substituted pyridine
12/03/2002	US6489344 For treatment diabetes in a human or animal subject
12/03/2002	US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
12/03/2002	US6489330 Or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of such as famciclovir; prophylactic treatment for kaposi's sarcoma or aids related disease
12/03/2002	US6489328 Heterocyclic compounds useful as inhibitors of tyrosine kinases
12/03/2002	US6489298 Contulakin-G, analogs thereof and uses thereof
12/03/2002	US6489297 Anti-neoplastic activity of novel vip peptide analogs using selected constrained amino acids such as diethylglycine, 1-aminocyclopentane carboxylic acid and di-n-propylglycine
12/03/2002	US6489295 Antagonists of intestinotrophic GLP-2 peptides
12/03/2002	US6489137 For use in cancer diagnostics; detection of the loss and or alteration of wild-type hubub1 genes in tumor tissues
12/03/2002	US6489134 Kinesin motor modulators derived from the marine sponge Adocia
12/03/2002	US6489128 Methods for detecting cancer of the central nervous system
12/03/2002	CA2414000A1 Pyridin-2-ylaminoalkylcarbonylglycyl-beta-alanine and derivatives
12/03/2002	CA2259343C Novel radiopharmaceutical compositions and matrices and uses thereof
12/03/2002	CA2255748C Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
12/03/2002	CA2117543C Dipeptidylquinazolones as anti-cancer agents
12/03/2002	CA2092914C Synergism of tnf and il-4
12/03/2002	CA2060544C Recombinant antibodies specific for a growth factor receptor
11/2002
11/28/2002	WO2002095417A2 PRE-mRNA SPLICING SCREENING ASSAY
11/28/2002	WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095051A2 Mage-a3 peptides presented by hla class ii molecules
11/28/2002	WO2002095041A1 Virus high effectively expressing the tumor interferon and specifically reproduction in tumor cells and the use thereof
11/28/2002	WO2002095034A2 A retinoic acid metabolizing cytochrome p450
11/28/2002	WO2002095025A1 Novel smg-1
11/28/2002	WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002	WO2002095007A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002	WO2002094980A2 Phytocystatin
11/28/2002	WO2002094881A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	WO2002094879A1 Antibodies specific for cd44v6
11/28/2002	WO2002094875A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION
11/28/2002	WO2002094873A2 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use
11/28/2002	WO2002094864A2 Human cdnas and proteins and uses thereof
11/28/2002	WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002	WO2002094861A2 Genes and proteins involved in the biosynthesis of enediyne ring structures
11/28/2002	WO2002094852A2 Taci-immunoglobulin fusion proteins
11/28/2002	WO2002094840A2 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094836A2 Methods for preparation and use of psorospermin analogs
11/28/2002	WO2002094835A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002	WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094814A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
11/28/2002	WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002	WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002	WO2002094808A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
11/28/2002	WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002	WO2002094788A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
11/28/2002	WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	WO2002094780A2 Kinases and phosphatases
11/28/2002	WO2002094754A1 Vitamin d analogues
11/28/2002	WO2002094379A1 Use and compositions of antiprogestins for treatment of prostate diseases
11/28/2002	WO2002094325A2 Cytotoxic cd44 antibody immunoconjugates
11/28/2002	WO2002094322A2 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug
11/28/2002	WO2002094319A1 Preventive or recurrence-suppressive agents for liver cancer
11/28/2002	WO2002094310A1 Anti-angiogenic and immunotherapeutic compositions for cancer treatment
11/28/2002	WO2002094306A1 Remedies for nervous tumor
11/28/2002	WO2002094298A1 Traditional chinese medicine for treatment and prevention of cancer
11/28/2002	WO2002094286A1 Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives
11/28/2002	WO2002094271A1 Targeted delivery of bioaffecting compounds for the treatment of cancer
11/28/2002	WO2002094268A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
11/28/2002	WO2002094265A1 A method of modulating nf-$g(k)b activity
11/28/2002	WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002	WO2002094261A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
11/28/2002	WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002	WO2002094196A2 Method of treatment for cancers associated with elevated
11/28/2002	WO2002094194A2 Compositions and methods for inhibiting metastasis
11/28/2002	WO2002094193A1 Methods for inhibiting angiogenesis
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002	WO2002094189A2 Compositions and methods for treating or preventing convulsions or seizures
11/28/2002	WO2002094186A2 Urazole compounds useful as anti-inflammatory agents

1 ... 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 ... 2211